MedTech giant Integer announced the completion of significant facility expansions in Ireland. The company will expand its reputation as the leading medical device contract development and manufacturing organization (CDMO) in Ireland, providing abundant support to the Irish economy through a sustained supply of MedTech capabilities.

Decades of Work Fulfils MedTech Aspirations in Ireland

Integer’s presence in Ireland spans 30 years.

Throughout these years, the company has consistently invested in its infrastructure, technology, and associates. The completion of these significant projects announced today as well as the acquisition of Aran Biomedical continue that trend, reinforcing Integer’s commitment to its Irish operations and customers. 

Joseph Dziedzic, Integer President and CEO said —

“Our expansion in Ireland provides Integer with the capacity and differentiated capabilities to amplify our customers’ innovation and help them bring products to market faster. Integer’s significant investment in Ireland demonstrates our commitment to supporting our customers’ growth and furthers our unparalleled ability to be their partner of choice for developing the next generation of lifesaving and life-enhancing medical therapies.”

The company officially opened its new European medical device innovation and manufacturing center in Galway, Ireland, on 20 September. This state-of-the-art facility adds to Integer 80,000 square-foot expansion of its guidewire manufacturing facility in New Ross, County Wexford. This expansion will enhance Integer’s capacity to produce high-quality medical devices and meet the needs of its global customer base. These investments demonstrate Integer’s commitment to growth and innovation in the medical device industry. By expanding its operations in Ireland, Integer is positioning itself as a leading provider of contract manufacturing services in Europe.

At the time of this announcement, John Harris, Integer Executive Vice President, Global Operations and Manufacturing Strategy said, “Since Integer, then Lake Region Medical, first expanded into Ireland 30 years ago, our local team of talented professionals has partnered with leading medical device companies to develop and supply innovative, high-quality products to customers around the globe.”

IDA Ireland CEO Michael Lohan said, “Integer’s continuing expansion in Ireland, following 30 years of success here, is a wonderful vote of confidence in the strong business growth opportunities that Ireland offers. The new manufacturing facility in Galway and the expansion in Wexford highlight the skills and talent that our regional locations can offer the medical technology sector. IDA Ireland is committed to bringing high-quality investment to regional locations around Ireland. I wish the Integer team continued success.”

John added, “We are excited about the expansion of our development and manufacturing network in Ireland and look forward to continued growth as we strengthen our ability to support our customers’ long-term strategy and technology needs, both in Ireland and globally.”

Integer’s recent investments in Ireland, including the acquisition of Aran Biomedical in 2022 and the expansion of its facilities, solidify the company’s commitment to the region’s thriving medical device industry.

Integer’s recent strategic moves strengthen the MedTech presence in Ireland, ensuring the industry’s ability to serve domestic and foreign customers. By expanding its capacity for manufacturing guidewires, catheters, medical textiles, and delivery systems, Integer is well-positioned to meet the growing demand for innovative medical devices.

Industry Speaks

Minister for Enterprise Trade & Employment Peter Burke TD said, “Huge congratulations to Integer on these significant announcements. A new European medical device innovation manufacturing facility in Galway, acquisition of Aran Biomedical, Spiddal, and indeed, expansion at their manufacturing facility in New Ross, County Wexford. This is great news for both the West and South-East regions and is in line with both Government and IDA’s commitment to ensuring balanced regional investments and employment opportunities on our island. The news further underscores Ireland’s global importance in the Lifesciences and MedTech industries and cements Integer’s commitment to our country. Thanks to Integer for their continued investment in Ireland, and I wish all the teams throughout the country the very best with these new and exciting projects.”

Minister of State for Trade Promotion, Digital and Company Regulation Dara Calleary TD said, “I very much welcome Integer’s announcement of three large scale regional investments. The West region has an ever increasing cohort of multinationals, including a significant number of Lifesciences and Med Tech companies. This news further marks the West as an import hub globally and is a huge boost for Galway and surrounding areas. I am also thrilled that this announcement includes an expansion at their Wexford facility, which will increase their manufacturing capacity by 70%. Friday’s event clearly highlights the importance Integer places on their Irish facilities as the company grows into the future. Good luck to all of those involved in these fantastic initiatives.”

Integer also continues to increase employment in Ireland, with more than 1,700 currently employed in the region. In Galway, the company is on track with its previously announced commitment to increase jobs by 100-200 in the coming years. In New Ross, Integer has increased its number of employees by 25% since 2020. It is expected this trend will continue in line with customer demand.

Source: IDA Ireland